358 related articles for article (PubMed ID: 17058766)
1. [Acetylsalicylic acid does not prevent cardiovascular disease. Poor scientific support for therapeutic guidelines according to primary prevention studies].
Mooe T
Lakartidningen; 2006 Sep 20-26; 103(38):2732-6. PubMed ID: 17058766
[No Abstract] [Full Text] [Related]
2. Low-dose aspirin for primary prevention of cardiovascular disease.
Bredie SJ; Wollersheim H; Verheugt FW; Thien T
Semin Vasc Med; 2003 May; 3(2):177-84. PubMed ID: 15199480
[TBL] [Abstract][Full Text] [Related]
3. [Acute coronary syndrome in patients using acetylsalicylic acid or warfarin].
Vik-Mo H; Hegbom K
Tidsskr Nor Laegeforen; 2004 Apr; 124(8):1105-6. PubMed ID: 15114389
[No Abstract] [Full Text] [Related]
4. Aspirin for primary prevention of cardiovascular events in people with diabetes.
Pignone M; Alberts MJ; Colwell JA; Cushman M; Inzucchi SE; Mukherjee D; Rosenson RS; Williams CD; Wilson PW; Kirkman MS; ; ;
J Am Coll Cardiol; 2010 Jun; 55(25):2878-86. PubMed ID: 20579547
[No Abstract] [Full Text] [Related]
5. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
Wallén H; Agren A; Nekludov M
Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
[No Abstract] [Full Text] [Related]
6. [Should warfarin and acetylsalicylic acid be withdrawn prior to tooth extraction?].
Løkken P; Skjelbred P
Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2498-9. PubMed ID: 16186871
[No Abstract] [Full Text] [Related]
7. [The polypill: not an effective strategy for reduction of cardiovascular disease].
Westerweel PE; van Wijk JP; Verhaar MC
Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1741. PubMed ID: 16114291
[TBL] [Abstract][Full Text] [Related]
8. Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions.
Hennekens CH; Sechenova O; Hollar D; Serebruany VL
J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):170-6. PubMed ID: 17056829
[TBL] [Abstract][Full Text] [Related]
9. Appropriate aspirin use for primary prevention of cardiovascular disease.
Miser WF
Am Fam Physician; 2011 Jun; 83(12):1380-6. PubMed ID: 21671538
[No Abstract] [Full Text] [Related]
10. New guidelines refine aspirin prescription. Task force offers recommendation for women and guidance on dosage.
Harv Heart Lett; 2009 Jun; 19(10):4-5. PubMed ID: 19681207
[No Abstract] [Full Text] [Related]
11. [Low-dosage ASA should not be given as primary prevention. The risk is greater than the benefit--also in high risk of cardiovascular disease].
Håkansson J; Hernborg A
Lakartidningen; 2010 Feb 3-9; 107(5):260-2. PubMed ID: 20297567
[No Abstract] [Full Text] [Related]
12. What next for low dose aspirin?
Morgan G
J Epidemiol Community Health; 2005 Jan; 59(1):3-4. PubMed ID: 15598718
[No Abstract] [Full Text] [Related]
13. [Aspirin in cardiovascular prevention: does the approach differ by gender?].
Temizhan A
Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():2-4. PubMed ID: 18160359
[TBL] [Abstract][Full Text] [Related]
14. Weighing the benefits and risks of aspirin for primary prevention of vascular disease.
Garg MK
J Assoc Physicians India; 2010 May; 58():331. PubMed ID: 21117359
[No Abstract] [Full Text] [Related]
15. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
16. [Uncertain benefit of low dosage ASA in peripheral arterial disease. Low dosage in symptomatic--individual assessment in asymptomatic disease].
Norgren L; Bergqvist D; Pärsson H
Lakartidningen; 2010 Jun; 107(23):1534-5. PubMed ID: 20617774
[No Abstract] [Full Text] [Related]
17. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.
Rodondi N; Bauer DC
Am J Med; 2004 Oct; 117(7):528-30. PubMed ID: 15464713
[No Abstract] [Full Text] [Related]
18. [Dipyridamole plus acetylsalicylic acid--who is to be trusted?].
Almdal TP; Eldrup E; Godtfredsen J; Kofoed-Enevoldsen A
Ugeskr Laeger; 1999 Aug; 161(34):4771-2. PubMed ID: 10500471
[No Abstract] [Full Text] [Related]
19. [Antiaggregation: aspirin].
Eichenberger A; Pontiggia L; Beer JH
Ther Umsch; 2003 Jan; 60(1):15-8. PubMed ID: 12638472
[TBL] [Abstract][Full Text] [Related]
20. The Polypill in the prevention of cardiovascular disease.
Wald DS; Wald NJ
Prev Med; 2011 Jan; 52(1):16-7. PubMed ID: 21130112
[No Abstract] [Full Text] [Related]
[Next] [New Search]
